Rigshospitalet, Denmark: Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
The registry lists 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies with Rigshospitalet, Denmark as lead sponsor. 3 are open to participants now and 1 have results posted.
Phase 2 1Phase 3 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Online Physical Activity and Health Counseling for Survivors of Childhood Acute Lymphoblastic LeukemiaNot yet recruitingNCT07042932Not applicable
- Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic LeukemiaRecruitingNCT05639673
- Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic LeukemiaRecruitingNCT04209244Not applicable
- NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic LeukemiaCompletedNCT00548431Phase 2Results posted
- Muscle Dysfunction in Patients With Haematological DiseasesActive, not recruitingNCT05150561
- Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantActive, not recruitingNCT04167683
- Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALLCompletedNCT01896752
- The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01886651
- Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01678508
- Second Malignant Neoplasms After Childhood ALL TherapyCompletedNCT01476462
- PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALLCompletedNCT01393249
- ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG AsparaginaseCompletedNCT00819351Phase 3
- ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation TherapyCompletedNCT00816049Phase 3